• Biosynthesis technology making strong advances
• Two promising pipeline candidates
• Inclusion in the CSE25 Index

InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF) continues down the fast track with its proprietary technology for the microbial biosynthesis of cannabinoids (http://dtn.fm/OBaw0). The company recently announced it has enabled the production of all four “gateway” cannabinoids using genetically engineered microorganisms. From these gateway substrates, production of all 90+ cannabinoids is possible via biosynthesis. InMed’s breakthrough stands to make the production of cannabis derivatives, including THC, CBD and trace cannabinoids, a much more commercially feasible proposition. The Company currently has two lead drug candidates that employ combinations of cannabinoids as the active ingredients. Moreover, as if to put a seal on its step forward, InMed is now included in the CSE25 Index, since it is now one of the twenty-five largest companies in the CSE Composite Index.

To date, over 90+ different cannabinoids have been isolated from the Cannabis sativa plant, the two best known being delta-9-tetrahydrocannabinol (THC), which is responsible for the ‘high’ derived from marijuana, and cannabidiol (CBD). Research into their pharmacological properties has shown that cannabinoids are not all created equally, however: some matter more than others, from a manufacturing process point-of-view. Four key gateway cannabinoids hold the door through which all others must pass:  CBGA, CBNA, CBGV, and CBGVA.  Following the most prevalent synthesis pathway in the plant, CBGA is formed from precursors; downstream enzymes then determine if CBGA diversifies to become tetrahydrocannabinolic acid (THCA), cannabidiolic acid (CBDA), cannabichromene acid (CBCA), or cannabigerol (CBG). Then, further reactions by synthases give rise to a multitude of the most common cannabinoids that so richly endow the plant, including THC and CBD.

InMed’s progress brings scale-up and commercialization of its disruptive biosynthesis process closer to fruition. Traditionally, sourcing cannabinoids has been accomplished by growing, harvesting, processing and purifying (via extraction) the cannabis plant. The extraction process can be expensive, and can result in unwanted by-products and impurities. Biosynthesis mimics the cannabinoid-creation process found in plants by utilizing a microbial host, resulting in pure, individual cannabinoids that will be devoid of the by-products and impurities seen with extraction. The InMed approach is to introduce cannabinoid DNA into E. coli bacteria that results in a biofermentation process, enabling a laboratory-based process under tightly controlled conditions. The process can be tailored to produce any of the 90+ “downstream” cannabinoids found naturally in the cannabis plant. InMed’s biosynthesis program will provide an alternative to the agricultural approach in a low cost and high quality process.  Currently, the Company is actively employing this production chassis to biosynthesize compounds for its pharmaceutical research programs. The possibilities of future growth opportunities are expanded significantly as InMed’s proprietary process may serve as foundation to supply cannabinoids to the pharmaceutical, nutraceutical, medical marijuana and even recreational sectors. What is the potential size of this market? GreenWave Advisors has stated the market for a single cannabinoid, CBD, could grow to $3 billion by 2021 in the US. alone.

Further signaling its rising fortune, InMed has announced (http://dtn.fm/bl2Jz) it is now part of the CSE25 Index, qualifying for the index as one of the twenty-five largest companies by market capitalization on the Canadian Stock Exchange (CSE).

InMed currently has two lead candidates in its drug pipeline. The first, INM-750, is for the treatment of a rare genetic skin disorder, called epidermolysis bullosa (EB), affecting roughly one out of every 20,000 births in the United States. The condition, which currently has no approved treatment or cure, has been called “The Worst Disease You’ve Never Heard Of” by the Dystrophic Epidermolysis Bullosa Research Association of America. INM-750 works two ways. First, it addresses the primary hallmarks of the disease: wound-healing, pain, inflammation, itch, and infection. Second, this compound may have the potential to reverse the course of the disease itself in some patients by upregulating compensatory keratins in the skin to replace defective ones.

The second candidate is INM-085 for the treatment of glaucoma, a leading cause of blindness, according to the Glaucoma Research Foundation. The drug reduces the elevated intra-ocular pressure that is often associated with glaucoma. It is targeting a large market. The National Institutes of Health estimates that more than 3 million Americans currently have glaucoma.

For more information, visit the company’s website at www.InMedPharma.com

Let us hear your thoughts: InMed Pharmaceuticals, Inc. Message Board

• RJDG’s business model consists of three acquisition-focused divisions: RJD Green Inc. Healthcare Services, Earthlinc Environmental Solutions, and Silex Holdings Inc.
• Medical billing, waste management, and interior decorating now represent the company’s primary market focus
• Success in their market niche, long-term stability, geographic size, and revenue are some criteria examined in acquisition targets

Even in high-growth, recession-resistant markets, an effective business model is required to maintain success. Small businesses can falter even if the economy is strong and demand is high. That is where RJD Green Inc. (OTC: RJDG) comes in. The holding company has developed a multi-division business model that enables it to focus on acquiring and managing assets in various markets. This method, first introduced in 2016, has so far proven its viability. The organization has created three divisions to support its business model – RJD Green Inc. Healthcare Services, Earthlinc Environmental Solutions, and Silex Holdings Inc.

RJD Green Healthcare Services focuses on the medical billing market. Its proprietary software and IT support services are used by healthcare payers and providers, and helps streamline the electronic payments process. Healthcare is a major market for all stakeholders and investors. It is always active despite the economic cycle, but the cost of operations and support is always a concern. The division acquired IoSoft Inc., a provider of payment technologies, services, and software that can be used by hospitals, individual providers, and healthcare provider networks. This system has even been integrated into the systems of Aetna, Blue Cross, CIGNA, and other healthcare payers, demonstrating the potential payout to investors involved in this market.

Earthlinc Environmental Solutions delivers green technologies and environmental services, mainly to clients in North America. Scheduled to launch in 2017, its first technology is anticipated to draw over $20 million in revenue within two years. Its first acquisition was Animal Waste Management, developer of a patented technology to process chicken and hog waste on farms. This technology produces an odorless, bacteria-free byproduct out of liquid, solid, and gas waste. The byproduct can be safely used as an animal feed filler. Liquids on the back end of the process can be re-used as ground water.

Serving the industrial and construction specialty services sectors, Silex Holdings Inc. has acquired high-growth assets such as Silex Interiors. The business support is expected to enable the countertops, cabinets, and kitchen and bath products manufacturer/distributor/installer to expand into major national markets. Rapid growth, both organically and through franchising, is expected; the company expects a 50 percent increase in revenues and profitability in 2017.

Silex’s acquisitions in the industrial contracting and building material products market are modeled to support immediate growth. They’re also chosen and designed to support businesses operating over wide geographical areas. For example, Silex Interiors can now operate 12 to 18 franchise locations and at least four corporately owned locations.

Overall, RJDG’s merger & acquisition strategy is strongly focused on organic growth. Businesses of interest must be viable in their market niche, and the company looks for long-term stability, geographic size, and the ability to penetrate additional markets. Also, it looks to acquire companies that have at least $5 million to $40 million in annual revenues. These are the criteria used to measure and predict whether the appropriate investment returns can be met.

For more information, visit the company’s website at www.RJDGreen.com

Let us hear your thoughts: RJD Green Inc. Message Board

• EVIO maintains cannabis labs in five states, and it plans to have 18 labs by the end of 2018 that provide testing to ensure the quality and safety of the cannabis supply
• The company’s goal is to become the industry’s largest cannabis testing company, says CEO
• Serving the legalized cannabis industry, EVIO sees California becoming the biggest marketplace globally. Estimates are that the cannabis market there could reach $4-$7 billion annually

EVIO, Inc. (OTCQB: EVIO) is readying itself for new testing rules in California, which it foresees as the largest cannabis marketplace in the world (http://dtn.fm/E7opD). Its labs in that state will analyze newly legalized recreational marijuana in January 2018. Its Yuba City, California lab is already testing cannabis under current rules, but they are expecting all new and more stringent requirements come January.

EVIO already has labs in five states and is planning to have 18 by the end of 2018. The publicly-traded Oregon-based company now has labs in Massachusetts, Florida, Oregon, Colorado, and California. EVIO serves the cannabis industry by testing for pesticides, solvents, micro-biological contaminants, heavy metals, and cannabinoids. It also provides the industry with advisory services including in the areas of compliance and product development.

EVIO is a life sciences company which provides the regulated cannabis industry with accredited analytical testing services. Part of its growth comes from license agreements, offering the EVIO brand to other labs. EVIO’s goal is to become the largest cannabis testing company in the industry, said William Waldrop, CEO and founder of the company (http://dtn.fm/yrCL2).

It anticipates that new testing rules for California will be announced before January, but based on draft rules already published, requirements are for testing for 66 pesticides, 22 solvents, and heavy metals. The metals include lead, arsenic, mercury, and cadmium. The proposed California analysis requirements will be similar to how EVIO is already testing in Oregon.

EVIO foresees that new testing rules for pesticides will be announced in November 2017. It also expects a high early failure rate on the cannabis it tests — the same pattern it saw in its home state of Oregon. It experienced a 25% failure rate in extracts and concentrates when the new rules were first introduced. But testing approvals increased later in the first year as growers quickly addressed the issues.

The new more stringent tests are important because EVIO sees California as not only a vibrant opportunity, but eventually the biggest cannabis marketplace in the world. Regimented regulatory oversight is to be expected, including lab testing, the company said. According to the San Diego Union-Tribune (http://dtn.fm/8GOmN), California’s cannabis industry could be worth from $4-$7 billion.

For more information, visit the company’s website at www.EVIOLabs.com

Let us hear your thoughts: EVIO, Inc. Message Board

As a generation that has grown up surrounded by technology and accustomed to the instant gratification of online games and social media, millennials have little interest in driving to the local gas station to play the lottery, compared to previous generations. In the interest of identifying future growth, a growing number of lottery operators are trying to recast their business model to attract younger players, whether it’s in the form of transforming the play into an experience or enabling users to purchase tickets online and pay with a credit or debit card, in the states where it is not commonplace due to state laws. A new lottery messenger service that allows subscribers to legally order and manage state lotto tickets online, LottoGopher Holdings, Inc. (OTCQB: LTTGF) (CSE: LOTO) (FRA: 2LG) hopes to successfully attract a larger millennial customer base with its unique approach that transforms the lottery buying experience into an interactive and more engaging process.

Even if overall lottery ticket sales continued to grow, rising 9 percent in 2016, the $80 billion industry is at risk if it doesn’t succeed to expand its customer base soon. A Gallup survey quoted by Reuters found that the number of young Americans playing the lottery has been declining steadily in the last decade (http://dtn.fm/5jIiU). In 2016, only one third of U.S. citizens aged 18 to 29 bought lottery tickets, compared to 39 percent in 2007. For comparison, people aged 50 to 64 played the lottery in larger numbers, with 61 percent of this group buying tickets last year, the report said.

There are several explanations for the gap, including millennials’ higher aversion to risk, as well as the fact that they are looking for different challenges and experiences that are more interactive, require a certain amount of skill and offer almost instant gratification. Most millennials don’t have the patience to wait for several days to find out if they won the lottery, as they consume entertainment content at a much faster rate than previous generations, a New Hampshire Lottery official explained, quoted by the same Reuters report.

But with laws regulating online lottery ticket sales, many lotto operators are struggling to come up with innovative ways of making their services more attractive for the younger public. This is where LottoGopher Holdings has hit the jackpot. With plans to move into 23 of 42 lottery states, the new lottery messenger service currently operates in California and is in full compliance with state and federal gaming laws.

Self-described as the first social lottery website, LottoGopher aims to radically transform the lottery buying experience by enabling users to securely order and manage their state lotto tickets exclusively online. Members pay a monthly subscription fee, similar to any film streaming service, and gain access to a platform that includes alerts, news and playing strategies, and more. Users are then able to buy tickets through the service, paying the same rates as in any brick-and-mortar store, and are given the possibility to either play individual tickets or join online groups to pool, paying with their credit or debit card. The LottoGopher platform is also mobile friendly and highly intuitive, making it very easy for users to purchase tickets for California’s SuperLotto Plus or two of North America’s most famous lotteries – Powerball or Mega Millions.

The service is already gaining traction in California, which has a $6.3 billion lottery market. LottoGopher is planning to disrupt the lottery industry by exporting its model to other states, with the goal of scoring $50 million in sales and increasing its number of subscribers to at least half a million by 2020.

For more information, visit the company’s website at www.LottoGopher.com

Let us hear your thoughts: LottoGopher Holdings Inc. Message Board

• Research reports the global compounding pharmacy industry will grow to $9.7 billion by 2021, exhibiting a six year CAGR of 5.3%
• TNTY’s goal is to acquire two industry groups in the Southeast, then go national
• Company names new president and CEO, intends to create three wholly-owned subsidiaries

True Nature Holding, Inc. (OTCQB: TNTY) has identified two acquisition opportunities in the fast-growing and high margin ‘compound’ pharmacy industry. They include the Southeast Group, a company of three units which did greater than $25 million in 2016, and the Florida Group that generated $2.7 million in 2016. Half of their all-cash business is in the veterinary market. Both are described in a TNTY 10Q filing (http://nnw.fm/aELF1).

TNTY is a development stage company seeking opportunistic acquisitions, beginning in the Southeast, of ‘compound’ pharmacies, pharmacies that formulate special therapeutic compounds to serve unique needs of a patient. Through combining or processing appropriate ingredients, compound pharmacies can change the form of a medication, from a solid pill to a liquid for example. It can also mean altering the taste or texture.

The goal of TNTY is be national, delivering economies of scale to the compound pharmacy industry, generating organic growth while acquiring such pharmacies through a four-step proprietary process that ends in profitable commercialization.

Global Market Insight sees the domestic market for compound pharmacies as $8 billion in 2016, and projected to grow at a 5% compound annual growth rate (CAGR) from 2017 through 2024 (http://nnw.fm/9caQ2). Persistence Market Research (PMR) found that the global compound pharmacy industry was projected to reach revenues of $7.09 billion by the end of 2016, exhibiting YOY growth of 4.5% (http://nnw.fm/z2uAE). PMR said the global market would achieve annual revenues of $9.75 billion with a CAGR of 5.3% over the forecast period 2015-2021. It says that the market’s CAGR will be stable and the North American Market is expected to dominate global growth.

Driving that growth, PMR says, will be blockbuster drugs going off-patent in 2016, a rise in demand for geriatric drugs, increased adoption of topical applications as well as cosmetic dermatological therapies.

TNTY believes there are more than 5,500 compounding pharmaceutical groups with combined annual sales of $5.6 billion and profits exceeding $1.5 billion. TNTY has identified a number of acquisition opportunities and plans to use debt and raise funds through a Regulation D offering.  After an initial acquisition is made, TNTY then plans to merge with an existing OTC traded company, then become a reporting company through an equity exchange transaction. To continue to grow, the company would then attempt to raise additional funding by registering its shares on an S-1 form, creating a market for them on NASDAQ.

TNTY has recently begun a restructuring. The company intends to create three wholly-owned subsidiaries: TN Retail, LLC; TN Compounding, LLC; and TN Technologies, LLC. It has named Thomas Burnell as its new president and CEO. Burnell has more than 25 years of experience in the health care and veterinary marketplaces, according to Dr. Jordan Balencic, chairman. Earlier, Burnell had been president of Boston Heart Diagnostics.

For more information, visit www.truenaturepharma.com

• Company’s vertically integrated business model designed to support rapid growth and position investors at the forefront of cannabis and hemp innovation
• New LOI signed with Canada’s Global Hemp Group and Colorado’s Space Cowboys will provide MCOA with the ability to cultivate, process and distribute quality hemp-derived CBD containing no THC
• Comprehensive network affiliate marketing program aims to build customer loyalty and help capture significant market share

With the legal cannabis and hemp industries continuously growing, from product development and manufacturing to adjacent services, so is the competition, making it increasingly difficult for companies in the field to stand out, despite the size of the market and the rising demand. In this competitive market, companies such as Marijuana Company of America, Inc. (OTC: MCOA) are successfully carving out a niche for themselves due to a unique strategic approach and business model.

Now legal for medical or recreational use in 29 states and the District of Columbia, marijuana continues to be an attractive industry for investors, with sales of roughly $6.7 billion in 2016, according to Arcview Research (http://dtn.fm/S3Ta0). The industry is expected to go over $22 billion by 2021, according to the same report. Other reports are a bit more conservative, with New Frontier Data research estimating the medicinal and recreational marijuana market to reach $18.37 billion by 2021 and $24.07 by 2025 (http://dtn.fm/H0Xqi). The hemp industry is also growing fast, with analysts expecting to see it rise from a market size of $688 million this year to a little over $1.8 billion by 2020, according to the Hemp Business Journal (http://dtn.fm/4ltjT). A large portion of the sales from this year were from hemp-derived CBD, with the sector recording $130 million in sales and growing at an aggregated growth rate of 53 percent, per the report.

The exponential growth of the legal cannabis market and the hemp-based CBD industry enables Marijuana Company of America to fully develop its vertically integrated business model, which is built around the idea of bringing together a diverse portfolio of investments and joint ventures representing synergistic business segments of the market that are uniquely positioned to bring added value to shareholders. Designed to serve as an umbrella for a variety of companies that participate in the legal cannabis industry, Marijuana Company of America aims to provide investors with the opportunity to become a driving force of hemp and cannabis innovation, processing and cultivation, as well as distribution, with the end goal of maintaining customer loyalty and capturing a hefty market share by developing valuable and recognizable brands.

With a commitment to quality both in terms of the turn-key services it provides to the industry and the products brought to market, Marijuana Company of America also aims to establish itself as a successful network affiliate marketing program (http://dtn.fm/4moWh) via wholly owned subsidiary hempSMART™, Inc. The subsidiary offers affiliates multiple opportunities to generate long-term income from sales and referrals, as well as the opportunity to build an affiliate organization to promote a range of quality CBD products, including hempSMART Brain and hempSMART Drops and additional products launching in Q4 2017. As part of its affiliate marketing program, hempSMART™ also offers support materials and training, giving affiliates access to high-quality products and the opportunity to enter large markets and develop a national customer base.

In addition to hempSMART™, Marijuana Company of America’s portfolio includes several companies involved in hemp cultivation and the development of optimal cultivation and processing facilities. The latest announcement by the company was a signed LOI to acquire 25% of Colorado-based hemp-derived CBD producer Space Cowboys, Inc. The agreement between Marijuana Company of America, Canadian Global Hemp Group (OTC: GBHPF) and Space Cowboys was announced in a press release on October 10 (http://dtn.fm/QguC2). Under the agreement, Marijuana Company of America and Global Hemp Group will invest $2.5 million in Space Cowboys to help expand its cultivation operations. In exchange, they will receive 25 percent equity in Space Cowboys, as well as access to a constant stream of high-quality CBD.

For more information, visit the company’s website at www.MarijuanaCompanyofAmerica.com

Let us hear your thoughts: Marijuana Company of America, Inc. Message Board

• Electric vehicle production is driving demand for lithium
• RGDCF controls five lithium properties
• Smart phones and other mobile devices also require lithium

With concern about dwindling supplies of lithium carbonate growing, prices for the compound used in the cathodes of batteries have more than doubled since 2015. Prices are expected to hit US$12,000 per tonne, according to the Driving Disruption report issued by investment bank UBS, and while there are adequate reserves of the metal, bringing it to market quickly enough may pose a challenge. This prognosis has manufacturers of electric vehicles scrambling to secure supplies. It is very likely some will go knocking on the doors of junior exploration companies like 92 Resources Corp. (TSX.V: NTY) (OTCQB: RGDCF) (FSE: R9G2). Among its three principal assets, 92 Resources has five that revolve around lithium. As a result, the company is poised to deliver supplies of lithium to EV manufacturers seeking to secure their supply chains.

Earlier this year, Volkswagen said that securing supplies of cobalt and lithium were two of its ‘greatest concerns’. And ‘BYD, the Chinese electric car and bus company part-owned by Warren Buffett, said it was talking to lithium producers in Chile about potential deals to secure lithium supply’. The race has been driven by rising estimates of EV production. In May 2017, UBS became the latest major analyst to up its forecast for EV penetration. The bank now estimates EVs will hit 14 percent penetration globally by 2025. This will require the lithium market to ‘to grow from its annual production of 182,000 tonnes to an average of 3.1m tonnes for 20 years to electrify the world’s fleet of vehicles’, according to the FT report.

RGDCF’s two major lithium assets are at Hidden Lake, approximately 40 km northeast of the city of Yellowknife, the capital of Canada’s Northwest Territories, and at their Corvette property, located 12 km south of the Trans-Taiga all-weather gravel road in the province of Quebec. The Hidden Lake Lithium Property consists of two mineral claims, totaling approximately 1,100 hectares. It is highly prospective for spodumene-bearing lithium pegmatites, with samples indicating between 1.37% and 3.01% Lithium superoxide (LiO2). The very high grades of lithium have been attributed to concentrations of coarse-grained spodumene and crystals of up to 36 inches long, with visual estimates across the dyke(s) ranging from 20% to 35%. The Corvette property consists of 76 claims totaling 3,891 hectares, and recently returned samples of 3.48% and 7.32% LiO2 from spodumene bearing pegmatite exposed at surface.

RGDCF recently acquired three new properties, including Corvette, and also located at Eastmain and Lac du Beryl, together consisting of 115 mineral claims on 14,710 acres, all rich in pegmatite. Pegmatite is a type of crystal-heavy igneous rock, and is a good source of ‘hard rock’ lithium, which represents about one-third of all global reserves.

With the lineup of EV manufacturers now a veritable alphabetic list of automakers, the fretting about demand has subsided. For the near future, the concern is supply: getting the metal out of the ground fast enough to satisfy demand from EV and mobile device makers. It won’t be surprising to see RGDCF’s valuation climb as lithium suitors court this modern energy solutions company.

For more information, please visit www.92Resources.com.

Let us hear your thoughts: 92 Resources Corp. Message Board

• Launch of Spanish-language Telemedicos USA to serve 58 million Hispanics in the U.S.
• Unique telemedicine model connects specialty physicians with rural care providers, patients
• MIHI building nationwide telemedicine network focusing on needs of underserved Americans

Medical Innovation Holdings, Inc. (OTC: MIHI) continues to transform the health care industry with the launch of Telemedicos USA, a Spanish-language health care platform designed to deliver much-needed services to the estimated 58 million Hispanics living in the United States. This minority population often experiences disparities when seeking out health care access because of insurance issues, language barriers and the lack of medical clinics located in rural areas of the country. Telemedicos USA was created to serve this demographic, the largest minority group in the United States, and its growing population base.

“This was a natural evolution for us,” MIHI CEO Jake Sanchez, stated in a news release. “We purposefully positioned MIHI for this market because we understand the nuances of providing services to such an ethnically diverse group that make up the Hispanic community.”

Telemedicos USA will use primary care, on-demand telemedicine services paired with 3PointCare’s specialty network of doctors, providing unparalleled access to health care. Telemedicos USA also will offer pharmaceuticals, alternative medicines and patient portals to create a cloud-based, electronic medical records (EMR) that travels with the patient.

MIHI offers a unique, proprietary telemedicine platform that fills a critical health care need facing millions of Americans living in rural, medically underserved areas. The company’s business model is designed to greatly increase not only health care access for people who struggle to find medical care, but administrative support to physicians in the field and the ability to grow their rural practices through more product and service offerings. This well-rounded approach, created through a variety of subsidiaries, serves as the foundational basis of a comprehensive health care-centric business ecosystem. MIHI intends to continue its expansion throughout the United States as it becomes the go-to primary health care resource for a long neglected section of the nation’s underserved population.

For more information, visit the company’s website at www.MedicalInnovationHoldings.com

Let us hear your thoughts: Medical Innovation Holdings, Inc. Message Board

• HighCom’s website showcases its two divisions – HighCom Armor Solutions, Inc., and BlastGard Technologies, Inc.
• The Department of Homeland Security has approved and certified the company’s ballistic armor and protective equipment
• The company maintains its ISO 9001:2008-certfied Quality Management System and supplies over 20,000 pieces of armor per month

A global leader in blast effects mitigation solutions, HighCom Global Security, Inc. (OTC: HCGS) has announced the launch of a new website that represents its security and defense products brand, pursuit of innovation, and its effective acquisition strategy. The site is a portal into the company’s brand and its services. It demonstrates what has enabled HighCom to reach a level of sustained growth and give customers and investors unique opportunities in this highly specialized field.

The website incorporates HCGS’s two main businesses. HighCom Armor Solutions, Inc. is a designer and tester of body armor and personal protective equipment; it’s also a leader in manufacturing and distributing these vital products, including hard and soft armor, to federal, state, and local law enforcement agencies. The company serves several military branches as well. Body armor products are sold directly on the website, making it easy for agencies to procure the equipment they need to protect personnel at all times.

A key part of HighCom is now BlastGard Technologies, Inc., a manufacturer and supplier of proprietary blast mitigation materials. Its BlastWrap® technology, used on new products and to retrofit others, can suppress the effects of blasts and the fires that can result. The technology has been used in structural walls, commercial aircraft, cargo containers, aboard naval vessels, and in fuel tanks. It’s also been implemented aboard offshore platforms, in fireworks plants, and by explosives manufacturers. The Safety Act certified product is on the “Approved Products List for Homeland Security” and approved by the General Services Administration.

HighCom Global Security has had much success in 2017, introducing new products to its line of armor, bullet proof vests, shields, helmets, plates, rifle armor, vest attachments, ballistic blankets, bags/pouches, and civilian armor systems. The latest additions to the product line include the Level IIIa elite high-performance soft armor panel, and the Level III++ multi-curve hard armor ballistic plate. In addition, the company has undergone a corporate restructuring that recently added Craig B. Campbell as HCGS’s chief executive officer. The reorganization also included a name change, formation of a new board of directors, and division of the business into two distinct entities. HighCom Armor Solutions now serves the global market of personal protective equipment, while BlastGard is devoted to blast mitigation technology serving a diverse global market.

Department of Defense contracts have represented a major portion of HighCom’s business. It supplied nearly a million pieces of ballistic armor over about a decade. Founded in 1997, the company has stepped up its output capacity and can now supply over 20,000 pieces of armor monthly. Its ISO 9001:2008-certfied Quality Management System continues to guarantee that all products manufactured and delivered by HCGS are approved by the International Organization of Standards, guaranteeing compliance and effectiveness. The company’s quality system has been in place since 2005.

For more information about the company, visit its website at www.HighComGlobal.com.

Let us hear your thoughts: HighCom Global Security, Inc. Message Board

• Topical product technology protected by patents
• Targeting $80 billion global skin care and dermatology market
• Product sales in China

Outsourcing has been the status quo in the pharmaceutical industry since long before the term gained notoriety. Large pharmaceutical and cosmeceutical companies, under pressure from rising R&D costs, have been farming out that part of their businesses for a long time now in an attempt to reduce costs. This approach also has the advantage of offloading the costs of patenting to the outsourcee. To obtain the advantages of adopting new technology, patent protection is vital to avoid copycatting. That is why the technology developed by Skinvisible, Inc. (OTCQB: SKVI), through its wholly owned subsidiary Skinvisible Pharmaceuticals, Inc., has been adopted by pharmaceutical and cosmeceutical companies since 1999. The Las Vegas, Nevada–based R&D company developed Invisicare® technology, which can be used to revitalize or create new medical or skin care products, allowing a company that licenses Skinvisible’s formulations to sell their own patented product and combat generic competitors.

Invisicare is a patented polymer delivery system that improves the delivery of topically applied skin care products, thereby enhancing the efficacy of the active ingredients. The unique process extends the time the product remains active on the skin and is specifically formulated to transport active ingredients that are insoluble in water without using alcohol, silicones, waxes, or other organic solvents.

Products utilizing Invisicare have been effective at bonding active ingredients to the skin for up to four hours and longer. Invisicare is non-occlusive; it allows normal skin respiration and perspiration while moisturizing and protecting against exposure from a wide variety of environmental irritants. When topically applied, products formulated with Invisicare adhere to the skin’s outer layers, forming a protective bond, resisting wash-off, and delivering targeted levels of therapeutic or cosmetic skin care agents to the skin. This allows enhanced delivery performance for a variety of topicals, resulting in improved efficacy, longer duration of action, reduced irritation and lower dosage of active agent required. The “invisible” polymer compositions that make up Invisicare wear off as part of the natural exfoliation process that removes the skin’s outer layer of cells.

With a $80 billion global dermatology market and a $30 billion global skin care over-the-counter (OTC) market, the patented polymer delivery system for topical products developed by Skinvisible, obviously, has many, many possible applications. The company has already inked an agreement (http://dtn.fm/ePdz3) with a large, well-known Canadian medical marijuana company: the first to attain ‘unicorn’ status in the industry. Under the agreement, the MMJ company will distribute Skinvisible’s topical products in Canada. The agreement covers two distinct product lines made with Skinvisible’s Invisicare technology. Skinvisible will develop unique topical hemp-based products to be launched by Canopy Hemp Corporation in Canada and the United States. In addition, the agreement includes potential cannabis-based topical products using Invisicare® technology when and if federal regulations permit CBD- or THC-infused topical products for sale in Canada.

While it continues to expand its licensing relationships, Skinvisible is developing its own line of OTC products, which is available for out-licensing. The 40+ products include antimicrobial hand sanitizers and skin care products for acne, skin fungi and atopic dermatitis. Skinvisible has also developed its own line of anti-aging products under the Kintari® brand (day cream, night cream, hand & body lotion, sunscreen and DermSafe), all available on www.Kintari.com. Kintari is a wholly owned subsidiary of Skinvisible.

In June 2017, the company announced that it had completed its first international sale of DermSafe® hand sanitizer in China (http://dtn.fm/83Enw) through its agent, InterSpace Global, Inc. The agreement with InterSpace Global facilitates the export of Skinvisible’s OTC products to mainland China, Hong Kong, Macau, Taiwan, Singapore, Malaysia, Thailand and Korea. In the beauty-conscious Chinese diaspora, Skinvisible is on track to repeat its U.S. success story.

For more information, visit the company’s website at www.Skinvisible.com

Let us hear your thoughts: Skinvisible, Inc. Message Board